OncoPrecision

OncoPrecision is a platform therapeutics company integrating patient-derived high-throughput biology with AI/ML to develop a pipeline of antibody-drug conjugates (ADCs) and bispecific antibodies, to target areas of high unmet medical need — primarily in oncology. Our clinically validated platform enhances the probability of success across drug discovery and development by generating robust translational human data before entering the clinic. Our company spun out of Dr. Gastón Soria’s Synthetic Lethality in Cancer Lab with a strong track record of successful drug discovery collaborations with leading global pharmaceutical companies. We are pioneering a patient-centric paradigm shift in the way transformational drugs are discovered and developed.